This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on April 18, 2025.

Return to the list of Patented Medicine Litigation page.

---

---

Latanoprost

MONOPROST, VYZULTA, XALATAN – Pfizer Canada Inc. (NOC Search)

Patents:

• 1208560: APOTEX, PHARMASCIENCE, RIVA
• 1314220: COBALT
• 1339132: , APOTEX, COBALT, PHARMASCIENCE, RIVA

Unknown/Other

• Infringement – T-67-02

APOTEX

• Infringement – T-393-14 (2016 FC 136)
• PM(NOC) – A-206-10 (2011 FCA 236) – T-124-08 (2010 FC 1238, 2010 FC 447) – T-893-11
• Section 8 – T-1064-13 (2017 FC 951)
• Appeal – A-334-17 – A-78-16 (2017 FCA 201)

COBALT

• PM(NOC) – T-1085-08 – T-1412-08

PHARMASCIENCE

• PM(NOC) – A-22-10 (2011 FCA 102) – T-2221-07 (2009 FC 1294, 2010 FC 1236)
• Other – T-1816-10

RIVA

• PM(NOC) – T-442-10

---

Return to the Patented Medicine Litigation page.